Eli Lilly's obesity pill, orforglipron, had a 12.4% average weight loss at its highest dose over 72 weeks, which means it's less effective than injections on the market
Mild side effects such as nausea, vomiting, diarrhea, and constipation were more frequent in the retatrutide group
Solanezumab is a humanized monoclonal antibody that targets the mid-domain of the A peptide for increasing A clearance [52]
Theres also a strong link between chronic inflammation and poor sleep, as inflammatory stress can disrupt deep sleep cycles and leave you feeling unrested no matter how many hours you log
Primary outcomes: Results Treatment with tirzepatide led to a lower risk of a composite of death from cardiovascular causes or worsening heart failure than placebo and improved health status in patients with heart failure with preserved ejection fraction and obesity
Semaglutide is designed to regulate appetite, not shut it off completely